Changxing Ou

546 total citations
13 papers, 140 citations indexed

About

Changxing Ou is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Changxing Ou has authored 13 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Changxing Ou's work include Eosinophilic Disorders and Syndromes (4 papers), COVID-19 Clinical Research Studies (4 papers) and Eosinophilic Esophagitis (3 papers). Changxing Ou is often cited by papers focused on Eosinophilic Disorders and Syndromes (4 papers), COVID-19 Clinical Research Studies (4 papers) and Eosinophilic Esophagitis (3 papers). Changxing Ou collaborates with scholars based in China, United States and Canada. Changxing Ou's co-authors include Zhufeng Wang, Jingyi Liang, Shiyue Li, Hongsheng Deng, Mei Jiang, Yingzhi Wang, Jie Yan, Jiaqian Chen, Qingling Zhang and Liping Luo and has published in prestigious journals such as Frontiers in Immunology, Medicine and Ecotoxicology and Environmental Safety.

In The Last Decade

Changxing Ou

12 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changxing Ou China 7 52 38 32 24 18 13 140
Marina Izak Israel 6 42 0.8× 21 0.6× 19 0.6× 11 0.5× 35 1.9× 16 199
Chenli Chang China 11 69 1.3× 56 1.5× 40 1.3× 21 0.9× 72 4.0× 16 252
Minyan Zeng China 8 53 1.0× 42 1.1× 16 0.5× 17 0.7× 16 0.9× 13 213
Ivica Smokovski North Macedonia 8 22 0.4× 21 0.6× 18 0.6× 17 0.7× 21 1.2× 21 153
Claire Tonry Ireland 9 66 1.3× 50 1.3× 12 0.4× 7 0.3× 55 3.1× 23 231
Tanima Dwivedi India 5 47 0.9× 19 0.5× 26 0.8× 16 0.7× 35 1.9× 14 154
Liu Sun China 4 66 1.3× 36 0.9× 47 1.5× 20 0.8× 17 0.9× 8 129
Xiaokai Feng China 7 65 1.3× 32 0.8× 36 1.1× 11 0.5× 66 3.7× 23 214

Countries citing papers authored by Changxing Ou

Since Specialization
Citations

This map shows the geographic impact of Changxing Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changxing Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changxing Ou more than expected).

Fields of papers citing papers by Changxing Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changxing Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changxing Ou. The network helps show where Changxing Ou may publish in the future.

Co-authorship network of co-authors of Changxing Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Changxing Ou. A scholar is included among the top collaborators of Changxing Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changxing Ou. Changxing Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lu, Chenyang, et al.. (2025). Residential greenness, genetic susceptibility, and asthma risk: Mediating roles of air pollution in UK and Chinese populations. Ecotoxicology and Environmental Safety. 296. 118199–118199.
2.
Zhang, Le, Linmei Li, Changxing Ou, et al.. (2024). Contribution of Pseudomonas aeruginosa − mediated club cell necroptosis to the bias of type 17 inflammation and steroid insensitivity in asthma. Journal of Advanced Research. 75. 137–149. 2 indexed citations
3.
Li, You, et al.. (2024). Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China. Annals of Medicine. 56(1). 2311843–2311843. 4 indexed citations
4.
Wang, Zhufeng, Changxing Ou, Wei Xu, et al.. (2022). Eosinophilia and Lung Cancer: Analysis From Real-World Data and Mendelian Randomization Study. Frontiers in Medicine. 9. 830754–830754. 9 indexed citations
5.
Zhang, Xuefei, Changxing Ou, Hongrui Zhan, et al.. (2022). Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling. Frontiers in Pharmacology. 13. 1051344–1051344. 10 indexed citations
6.
Xiao, Jing, Shaohua Lu, Xufei Wang, et al.. (2022). Serum Proteomic Analysis Identifies SAA1, FGA, SAP, and CETP as New Biomarkers for Eosinophilic Granulomatosis With Polyangiitis. Frontiers in Immunology. 13. 866035–866035. 6 indexed citations
7.
Li, Haijun, Bin Zhang, Yumei Liu, et al.. (2021). Machine learning models for predicting critical illness risk in hospitalized patients with COVID-19 pneumonia. Journal of Thoracic Disease. 13(2). 1215–1229. 13 indexed citations
8.
Dong, Cong, Changxing Ou, Xueyan Zhang, et al.. (2021). Serum Cytokine Profiling Identifies Axl as a New Biomarker Candidate for Active Eosinophilic Granulomatosis With Polyangiitis. Frontiers in Molecular Biosciences. 8. 653461–653461. 11 indexed citations
9.
Li, Haijun, Wenjun Le, Jianyu Li, et al.. (2021). CT Quantification of COVID-19 Pneumonia at Admission Can Predict Progression to Critical Illness: A Retrospective Multicenter Cohort Study. Frontiers in Medicine. 8. 689568–689568. 8 indexed citations
10.
Chen, Huifang, Liping Luo, Jiaqian Chen, et al.. (2021). TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis. Cell Death and Disease. 12(10). 938–938. 21 indexed citations
11.
Ou, Changxing, Ning Lai, You Li, et al.. (2021). Severe asthma with viral infection can develop into eosinophilic granulomatosis with polyangiitis. PubMed. 2(4). 249–254. 1 indexed citations
12.
Wang, Zhufeng, Hongsheng Deng, Changxing Ou, et al.. (2020). Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19. Medicine. 99(48). e23327–e23327. 53 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Izak Breakdown of academic impact, for papers by Chenli Chang Breakdown of academic impact, for papers by Minyan Zeng Breakdown of academic impact, for papers by Ivica Smokovski Breakdown of academic impact, for papers by Claire Tonry Breakdown of academic impact, for papers by Tanima Dwivedi Breakdown of academic impact, for papers by Liu Sun Breakdown of academic impact, for papers by Xiaokai Feng
Rankless by CCL
2026